Publication Date
1-1-2022
Journal
PLoS One
DOI
10.1371/journal.pone.0265419
PMID
35390031
PMCID
PMC8989323
PubMedCentral® Posted Date
4-7-2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Adipose Tissue, Adrenomedullin, Diabetes, Gestational, Female, Fetal Macrosomia, Humans, Lipids, Obesity, Omentum, Pregnancy, Subcutaneous Fat, Tumor Necrosis Factor-alpha
Abstract
Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy but the underlying mechanism remains obscure. The aims of this study are to examine if omental adipose tissue (OMAT) and subcutaneous AT (SCAT) differentially express proinflammatory and lipid metabolic adipokines, and if so, whether their regional differences have implications on lipid metabolism in GDM. Paired samples of OMAT and SCAT were excised from pregnant women in scheduled Cesarean sections with non-obese (NOBS), obese (OBS) and GDM. The results showed that the mRNA of monocyte chemoattractant protein (MCP)-1, macrophage marker CD68, and cytokines IL-6, IL-8, and TNF-α are increased in OMAT from GDM women compared to that in NOBS and OBS women (P<0.05). Glucose and TNF-α dose-dependently enhanced ADM and its receptor components CRLR and RAMPs in human adipocytes. Immunofluorescence showed that ADM and its receptor components are higher in OMAT from GDM women compared to non-GDM women. Further, basal lipolysis was greater in OMAT than in SCAT and ADM stimulates further glycerol release in OMAT, but not in SCAT, and these increases are reduced by ADM antagonist, ADM22-52. We therefore conclude that elevated ADM and its receptor expressions by OMAT, but not by SCAT appear to contribute to the lipid dysregulation in GDM women, and manipulation of ADM may represent one of the novel approaches in minimizing the risk of GDM-related fetal overgrowth.
Included in
Endocrinology, Diabetes, and Metabolism Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons